secwatch.observer — SEC 8-K summary
======================================

Issuer:     PepGen Inc. (PEPG)
CIK:        0001835597
Form:       8-K
Filed at:   2025-12-08T23:59:59+00:00
Accession:  0001193125-25-310544
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PepGen appoints Joseph Vittiglio as Chief Business and Legal Officer
--------------------------------------------------------------------

- Joseph Vittiglio named Chief Business and Legal Officer, effective December 8, 2025.
- He brings 20+ years of biotech legal, compliance, and business development experience.
- Most recently served as Chief Business and Legal Officer at bluebird bio.
- At bluebird, he helped launch 3 gene therapies and completed over $400M in financings.
- He previously led legal and business functions at Finch Therapeutics and AMAG Pharmaceuticals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835597/000119312525310544/0001193125-25-310544-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835597/000119312525310544/pepg-20251208.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-310544

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer